Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
KJ Apa stars as Jimmy Stewart in new biopic: See his transformation - 2Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
- 3Middle East hotels hit pandemic-era lows amid Iran war
- 4Journalists killed by Israeli strike in southern Lebanon
- 5Scientists document a death from a meat allergy tied to certain ticks
- Top 5 Top of the line Books of the Year
- From Exemplary to Current: Famous Rings Available
- Investigating Remarkable Espresso Flavors: Upgrade Your Day to day Blend
- Turning into a Distributed Writer: My Composing Process
- German-Polish man charged with calling for attacks on top politicians
- Eleven arrested over mass shooting in South Africa tavern
- Arctic sea ice hits lowest winter level as heat records are shattered worldwide
- Which European countries have mandatory or voluntary military service
- Obamacare enrollment declines as US subsidies expire
